Maryland Department of Health and Mental Hygiene (DHMH) Infectious Disease and Environmental Health Administration (IDEHA)

PROVIDER ALERT: Emerging Cephalosporin-Resistant Gonorrhea & Increasing Rates of Gonorrhea in Maryland

October 1, 2011

The Centers for Disease Control and Prevention (CDC) has issued several recent alerts about decreased cephalosporin susceptibility in N. gonorrhoeae (GC) isolates in the U.S., and treatment failures in Europe and Asia. This is a significant concern because treatment options are now limited to one class of antibiotics – cephalosporins. For GC provider alerts and CDC treatment recommendations, visit: www.cdc.gov/std/Gonorrhea/org/ and www.cdc.gov/std/treatment/2010/.